Ilumya has secured marketing authorisations from more than 55 health authorities worldwide.

Get all latest news, photos, videos, top news about Sun Pharma India. Explore Sun Pharma CEO, Sun Pharma chairman, Sun Pharma market cap, Sun Pharma share ...

Sun Pharma is transitioning its US business from low-margin generics to high-value specialty and innovative therapies.

Discover the Sun Pharmaceutical Industries Stock Liveblog, your go-to destination for real-time updates and comprehensive analysis of a top-performing stock. Keep track of Sun Pharmaceutical ...

Sun Pharmaceutical Industries Ltd. closed 2.99% short of its 52-week high of 1,850.95 rupees, which the company achieved on May 2nd.

Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715, "Sun Pharma" and includes its subsidiaries and/or associated companies) announced that the US ...

According to an HSBC report, the entry of generics could unlock a $256 million to $512 million market opportunity, with early movers like Dr Reddy's Laboratories, Sun Pharma and Alkem Laboratories ...

Welcome to the Sun Pharma Stock Liveblog, your real-time source for the latest updates and comprehensive analysis on a ...

Sun Pharma’s campaign urges Indians to prioritise heart health through daily actions: Our Bureau, Mumbai Monday, March 2, 2026, 17:20 Hrs [IST] Sun Pharmaceutical Industries Lim ...

Sun Pharmaceutical Industries Ltd. closed 3.70% short of its 52-week high of 1,850.95 rupees, which the company reached on May 2nd.

A trio of Indian drugmakers—Alembic Pharmaceuticals, Sun Pharmaceutical and Glenmark Pharmaceuticals—issued separate voluntary U.S. drug recalls in recent weeks due to either the presence of ...